FEED Validator

for Atom and RSS and KML

Congratulations!

This is a valid RSS feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

line 38, column 0: content:encoded should not contain decoding attribute (22 occurrences) [help]

                      <img decoding="async" src="https://mma.prnewswire.com/ ...

line 81, column 0: style attribute contains potentially dangerous content: position (7 occurrences) [help]
```
<div id="divReleaseHighlight5a71" style="border-top: 1px solid; border-botto ...
```
line 222, column 0: content:encoded should not contain loaded attribute (2 occurrences) [help]
```
 <img id='img_pixel' src='https://bwi-api-react.businesswireindia.com/ima ...
```
line 222, column 0: content:encoded should not contain onload attribute (2 occurrences) [help]
```
 <img id='img_pixel' src='https://bwi-api-react.businesswireindia.com/ima ...
```

line 273, column 0: content:encoded should not contain loading attribute (3 occurrences) [help]

                  <img loading="lazy" decoding="async" title="Cision" width= ...

line 454, column 0: content:encoded should not contain referrerpolicy attribute (2 occurrences) [help]
```
<img alt="" src='https://ml.globenewswire.com/media/YzNmMDk2MzctMDk4ZC00Z ...
```

Source: https://nynewscast.com/feed/

<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
<title>NY Newscast</title>
<atom:link href="https://nynewscast.com/feed/" rel="self" type="application/rss+xml" />
<link>https://nynewscast.com</link>
<description>Just another WordPress site</description>
<lastBuildDate>Tue, 14 Oct 2025 11:16:00 +0000</lastBuildDate>
<language>en-US</language>
<sy:updatePeriod>
hourly </sy:updatePeriod>
<sy:updateFrequency>
1 </sy:updateFrequency>
<generator>https://wordpress.org/?v=6.8.3</generator>
<item>
<title>Morgan Stanley Raises JOYY (JOYY.US) Target Price from US$40 to US$62 on Signs of Live Streaming Recovery and Attractive Shareholder Returns</title>
<link>https://nynewscast.com/morgan-stanley-raises-joyy-joyy-us-target-price-from-us40-to-us62-on-signs-of-live-streaming-recovery-and-attractive-shareholder-returns-183770/</link>
<comments>https://nynewscast.com/morgan-stanley-raises-joyy-joyy-us-target-price-from-us40-to-us62-on-signs-of-live-streaming-recovery-and-attractive-shareholder-returns-183770/#respond</comments>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 11:16:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/morgan-stanley-raises-joyy-joyy-us-target-price-from-us40-to-us62-on-signs-of-live-streaming-recovery-and-attractive-shareholder-returns-183770/</guid>
<description><![CDATA[SINGAPORE, Oct. 14, 2025 /PRNewswire/ — Morgan Stanley has raised its target price for JOYY (JOYY.US) to US$62 from US$40, reflecting improving fundamentals in JOYY’s core business, accelerating advertising growth, and attractive shareholder returns. The firm also highlighted JOYY’s robust cash position and attractive shareholder return program as key factors offering downside protection. Live-streaming business […]]]></description>
<content:encoded><![CDATA[
SINGAPORE, Oct. 14, 2025 /PRNewswire/ — Morgan Stanley has raised its target price for JOYY (JOYY.US) to US$62 from US$40, reflecting improving fundamentals in JOYY’s core business, accelerating advertising growth, and attractive shareholder returns. The firm also highlighted JOYY’s robust cash position and attractive shareholder return program as key factors offering downside protection.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">

<a href="https://mma.prnewswire.com/media/1887625/1_Logo.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/1887625/1_Logo.jpg" title="(PRNewsfoto/JOYY Inc)" alt="(PRNewsfoto/JOYY Inc)"></img> 
</a>

</div>

Live-streaming business may have bottomed out: Morgan Stanley thinks JOYY’s live steaming business may have bottomed out since 2Q25, after reporting 1% QoQ growth and positive management comments on revenue growth. The report expects further QoQ improvement in 2H25 and more growth in 2026-2027.

Advertising business to be the main growth driver in 2026 
–2027: The report notes that JOYY’s advertising business continued its strong revenue momentum in the first half of 2025, following more than 175% year-over-year growth in 2024. Morgan Stanley expects this momentum to persist, forecasting 26% year-over-year growth in 2H25 and 20% in 2026.

Attractive dividends and buybacks of US$300mn annually in 2025-2027: The company previously announced a three-year quarterly dividend policy totaling approximately US$600 million, together with a share repurchase program of up to US$300 million during 2025-2027. In 1H25, JOYY allocated US$135 million to quarterly dividends and share buybacks. Morgan Stanley assumes US$300 million in annual investor returns, including dividends and share buybacks.
 

<img decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=CN97282&sd=2025-10-14"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/morgan-stanley-raises-joyy-joyyus-target-price-from-us40-to-us62-on-signs-of-live-streaming-recovery-and-attractive-shareholder-returns-302583333.html" target="_blank">https://www.prnewswire.com/news-releases/morgan-stanley-raises-joyy-joyyus-target-price-from-us40-to-us62-on-signs-of-live-streaming-recovery-and-attractive-shareholder-returns-302583333.html</a>
SOURCE JOYY Inc.
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=CN97282&Transmission_Id=202510140716PR_NEWS_USPR_____CN97282&DateId=20251014" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. NYnewscast.com takes no editorial responsibility for the same.
]]></content:encoded>
<wfw:commentRss>https://nynewscast.com/morgan-stanley-raises-joyy-joyy-us-target-price-from-us40-to-us62-on-signs-of-live-streaming-recovery-and-attractive-shareholder-returns-183770/feed/</wfw:commentRss>
<slash:comments>0</slash:comments>
</item>
<item>
<title>Brogidirsen (NS-089/NCNP-02) 3.5 Year Clinical Trial Data for the Treatment of Duchenne Muscular Dystrophy Presented at 2025 World Muscle Society Congress</title>
<link>https://nynewscast.com/brogidirsen-ns-089-ncnp-02-3-5-year-clinical-trial-data-for-the-treatment-of-duchenne-muscular-dystrophy-presented-at-2025-world-muscle-society-congress-183771/</link>
<comments>https://nynewscast.com/brogidirsen-ns-089-ncnp-02-3-5-year-clinical-trial-data-for-the-treatment-of-duchenne-muscular-dystrophy-presented-at-2025-world-muscle-society-congress-183771/#respond</comments>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 11:13:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/brogidirsen-ns-089-ncnp-02-3-5-year-clinical-trial-data-for-the-treatment-of-duchenne-muscular-dystrophy-presented-at-2025-world-muscle-society-congress-183771/</guid>
<description><![CDATA[PARAMUS, N.J., Oct. 14, 2025 /PRNewswire/ — NS Pharma, Inc. (NS Pharma), a biopharmaceutical leader in rare disease and subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that the National Center of Neurology and Psychiatry (NCNP, Kodaira City; President, Kazuyuki Nakagome) presented 3.5-year efficacy and safety data from the open-label extension of an […]]]></description>
<content:encoded><![CDATA[
PARAMUS, N.J., Oct. 14, 2025 /PRNewswire/ — NS Pharma, Inc. (NS Pharma), a biopharmaceutical leader in rare disease and subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that the National Center of Neurology and Psychiatry (NCNP, Kodaira City; President, Kazuyuki Nakagome) presented 3.5-year efficacy and safety data from the open-label extension of an investigator-initiated clinical trial of brogidirsen (NS-089/NCNP-02) for the treatment of Duchenne muscular dystrophy (DMD) at the 30th annual International Congress of the World Muscle Society from October 7 to 11, 2025.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">

<a href="https://mma.prnewswire.com/media/2377806/NS_Pharma_Inc__Logo.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/2377806/NS_Pharma_Inc__Logo.jpg" title="Logo for NS Pharma, Inc. (PRNewsfoto/NS Pharma, Inc.)" alt="Logo for NS Pharma, Inc. (PRNewsfoto/NS Pharma, Inc.)"></img> 
</a>

</div>
<div id="divReleaseHighlight5a71" style="border-top: 1px solid; border-bottom: 1px solid; border-color: Gray; color: gray; width: 200px; float: left; position: relative; margin: 5px 10px 5px 10px; text-align: justify;" contenteditable="false">“These data suggest the potential for brogidirsen to slow progression in DMD patients amenable to exon 44 skipping”</div>
Brogidirsen is an antisense oligonucleotide co-discovered by Nippon Shinyaku and NCNP as an investigational therapy for DMD patients with dystrophin gene mutations that are amenable to exon 44 skipping.
“These long-term motor function data suggest the potential for brogidirsen to slow disease progression in DMD patients amenable to exon 44 skipping and support the robust increases in dystrophin production seen earlier in the trial,” said NS Pharma President, Yukiteru Sugiyama, Ph.D. “We are proud to offer hope to families and continue to demonstrate our commitment to the DMD community
The presented data are based on the investigator-initiated clinical trial conducted by NCNP and its extension study conducted by Nippon Shinyaku. These studies evaluated the efficacy and safety of brogidirsen in 6 participants who received weekly IV dosing of brogidirsen.
Findings include:
<ul type="disc">
<li>
Consistent functional benefits – High exon 44 skipping efficiency and dystrophin expression levels were observed in biopsied muscles at week 25/26 and week 99/100.</li>
<li>
Maintenance of motor function – Participants who remain ambulant after long-term brogidirsen administration maintained their motor function in evaluations including North Star Ambulatory Assessment.</li>
<li>
Acceptable safety profile – After 3.5-year of receiving brogidirsen, no serious or severe adverse events, or anaphylaxis related to long-term brogidirsen administration, were reported, and there were no discontinuations.</li>
</ul>
These findings support the potential of brogidirsen to modify the progression of DMD. This long-term extension trial is ongoing to investigate the efficacy and safety of longer-term administration.
Further, a global Phase II study of brogidirsen is being conducted by Nippon Shinyaku and NS Pharma, Inc. (Headquarters: New Jersey, USA; President: Yukiteru Sugiyama). Learn more at <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4530299-1&h=1707804833&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT05996003&a=ClinicalTrials.gov" target="_blank" rel="nofollow">ClinicalTrials.gov</a>.

About Duchenne Muscular Dystrophy (DMD) Duchenne is a form of muscular dystrophy that occurs primarily in males. It causes progressive weakness and loss of skeletal, cardiac, and respiratory muscles. Early signs of DMD may include delayed ability to sit, stand or walk. There is a progressive loss of mobility, and by adolescence, patients with Duchenne may require the use of a wheelchair. Cardiac and respiratory muscle problems begin in the teenage years and lead to serious, life-threatening complications. For more information, please visit <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4530299-1&h=1065872598&u=https%3A%2F%2Fwespeakduchenne.com%2F&a=wespeakduchenne.com" target="_blank" rel="nofollow">wespeakduchenne.com</a>.

About NS Pharma, Inc. NS Pharma, Inc., is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. NS Pharma is a registered trademark of the Nippon Shinyaku Co., Ltd. For more information, please visit <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4530299-1&h=3027260373&u=https%3A%2F%2Fwww.nspharma.com%2F&a=nspharma.com" target="_blank" rel="nofollow">nspharma.com</a>.
US Media Contact: <a href="mailto:media@nspharma.com" target="_blank" rel="nofollow">media@nspharma.com</a>

<img decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=NY95215&sd=2025-10-14"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/brogidirsen-ns-089ncnp-02-3-5-year-clinical-trial-data-for-the-treatment-of-duchenne-muscular-dystrophy-presented-at-2025-world-muscle-society-congress-302580951.html" target="_blank">https://www.prnewswire.com/news-releases/brogidirsen-ns-089ncnp-02-3-5-year-clinical-trial-data-for-the-treatment-of-duchenne-muscular-dystrophy-presented-at-2025-world-muscle-society-congress-302580951.html</a>
SOURCE NS Pharma, Inc.
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY95215&Transmission_Id=202510140713PR_NEWS_USPR_____NY95215&DateId=20251014" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. NYnewscast.com takes no editorial responsibility for the same.
]]></content:encoded>
<wfw:commentRss>https://nynewscast.com/brogidirsen-ns-089-ncnp-02-3-5-year-clinical-trial-data-for-the-treatment-of-duchenne-muscular-dystrophy-presented-at-2025-world-muscle-society-congress-183771/feed/</wfw:commentRss>
<slash:comments>0</slash:comments>
</item>
<item>
<title>Greenstein & Pittari, LLP: Protecting Victims of Airbnb & Short-Term Rental Accidents in New York City</title>
<link>https://nynewscast.com/greenstein-pittari-llp-protecting-victims-of-airbnb-short-term-rental-accidents-in-new-york-city-183772/</link>
<comments>https://nynewscast.com/greenstein-pittari-llp-protecting-victims-of-airbnb-short-term-rental-accidents-in-new-york-city-183772/#respond</comments>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 11:11:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/greenstein-pittari-llp-protecting-victims-of-airbnb-short-term-rental-accidents-in-new-york-city-183772/</guid>
<description><![CDATA[NEW YORK, Oct. 14, 2025 /PRNewswire/ — Airbnb, VRBO, and other short-term rental platforms have reshaped the way travelers experience New York. Yet, when a rental property is unsafe or negligently maintained, guests can suffer devastating injuries – leaving them unsure of who is legally responsible. Under New York premises liability law, multiple parties may […]]]></description>
<content:encoded><![CDATA[
NEW YORK, Oct. 14, 2025 /PRNewswire/ — Airbnb, VRBO, and other short-term rental platforms have reshaped the way travelers experience New York. Yet, when a rental property is unsafe or negligently maintained, guests can suffer devastating injuries – leaving them unsure of who is legally responsible.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">

<a href="https://mma.prnewswire.com/media/2219415/NYC_Law_Firm_Logo.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/2219415/NYC_Law_Firm_Logo.jpg" title="nycLawFirm.com (PRNewsfoto/Greenstein & Milbauer, LLP)" alt="nycLawFirm.com (PRNewsfoto/Greenstein & Milbauer, LLP)"></img> 
</a>

</div>
Under New York premises liability law, multiple parties may share responsibility for unsafe rental conditions, including:
<ul type="disc">
<li>
Hosts & Property Owners – obligated to maintain safe conditions and comply with NYC codes.</li>
<li>
Property Management Companies – responsible if they fail to inspect or repair hazards.</li>
<li>
Maintenance or Cleaning Contractors – liable when their negligence creates risks.</li>
<li>
Homeowners Associations – accountable for unsafe common areas.</li>
<li>
Platforms such as Airbnb or VRBO – rarely directly liable, but may face claims if they knowingly allow unsafe listings.</li>
</ul>
In a recent case filed in the Supreme Court of Suffolk County (600526/2022), a guest fell seven feet from a porch after a defective railing collapsed at an Airbnb property. The fall caused severe injuries, including a fractured heel and a blood clot. This case highlights the dangers of poorly maintained rentals and the complex liability issues involved.
This is just one example. Common short-term rental accidents include slip-and-falls, broken stairs, collapsing balconies, fires from faulty wiring, carbon monoxide poisoning, and negligent security incidents.
“At Greenstein & Pittari, LLP, we fight for New Yorkers and visitors injured in unsafe Airbnb and short-term rental properties,” said Robert Greenstein, Partner at Greenstein & Pittari, LLP. “These cases require navigating overlapping insurance policies, strict rental regulations, and disputes over who is responsible. Our mission is to ensure victims are not left to shoulder the burden alone.”

Free Consultations & No Fees Unless You Win

The firm offers free consultations and works on a contingency fee basis, meaning clients pay nothing unless compensation is recovered. Victims can call 1-800-VICTIM2 (1-800-842-8462) to speak directly with an experienced New York Airbnb accident lawyer.

About Greenstein & Pittari, LLP

Greenstein & Pittari, LLP is a trusted New York litigation firm dedicated to personal injury, municipal liability, and civil rights cases. With offices in New York City, the firm serves clients across Manhattan, Brooklyn, Queens, the Bronx, Staten Island, Yonkers, and Nassau County. Known for their aggressive advocacy, meticulous preparation, and proven results, the attorneys at Greenstein & Pittari have secured millions of dollars in compensation for injury victims.

Media Contact


Press Office 
Greenstein & Pittari, LLP <img src="https://s.w.org/images/core/emoji/16.0.1/72x72/1f4de.png" alt="📞" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 1-800-842-8462 <img src="https://s.w.org/images/core/emoji/16.0.1/72x72/2709.png" alt="✉" class="wp-smiley" style="height: 1em; max-height: 1em;" /> RGreenstein@nycLawFirm.com <img src="https://s.w.org/images/core/emoji/16.0.1/72x72/1f310.png" alt="🌐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4531388-1&h=890358906&u=http%3A%2F%2Fwww.nyclawfirm.com%2F&a=www.nycLawFirm.com" target="_blank" rel="nofollow">www.nycLawFirm.com</a>

<img decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=NY96434&sd=2025-10-14"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/greenstein--pittari-llp-protecting-victims-of-airbnb--short-term-rental-accidents-in-new-york-city-302582812.html" target="_blank">https://www.prnewswire.com/news-releases/greenstein–pittari-llp-protecting-victims-of-airbnb–short-term-rental-accidents-in-new-york-city-302582812.html</a>
SOURCE Greenstein & Pittari, LLP
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY96434&Transmission_Id=202510140711PR_NEWS_USPR_____NY96434&DateId=20251014" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. NYnewscast.com takes no editorial responsibility for the same.
]]></content:encoded>
<wfw:commentRss>https://nynewscast.com/greenstein-pittari-llp-protecting-victims-of-airbnb-short-term-rental-accidents-in-new-york-city-183772/feed/</wfw:commentRss>
<slash:comments>0</slash:comments>
</item>
<item>
<title>Reghelps SRC Launches Specialized Clinical Investigation, PMCF, and IVD Performance Evaluation Services in India</title>
<link>https://nynewscast.com/reghelps-src-launches-specialized-clinical-investigation-pmcf-and-ivd-performance-evaluation-services-in-india-183773/</link>
<comments>https://nynewscast.com/reghelps-src-launches-specialized-clinical-investigation-pmcf-and-ivd-performance-evaluation-services-in-india-183773/#respond</comments>
<dc:creator><![CDATA[Business Wire India]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 10:37:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/reghelps-src-launches-specialized-clinical-investigation-pmcf-and-ivd-performance-evaluation-services-in-india-183773/</guid>
<description><![CDATA[Reghelps SRC, a newly established Contract Research Organization (CRO) in India, announced the launch of its comprehensive clinical research services for global Medical Device and In-Vitro Diagnostic Device (IVD) manufacturers. Business Wire India Reghelps SRC, a newly established Contract Research Organization (CRO) in India, announced the launch of its comprehensive clinical research services for global […]]]></description>
<content:encoded><![CDATA[Reghelps SRC, a newly established Contract Research Organization (CRO) in India, announced the launch of its comprehensive clinical research services for global Medical Device and In-Vitro Diagnostic Device (IVD) manufacturers. 
Business Wire India
Reghelps SRC, a newly established Contract Research Organization (CRO) in India, announced the launch of its comprehensive clinical research services for global Medical Device and In-Vitro Diagnostic Device (IVD) manufacturers. 
 
With India emerging as a globally preferred destination for clinical research, <a href="https://www.reghelps.com/" style="color:#467886; text-decoration:underline">Reghelps SRC</a> is committed to accelerating clinical investigations and performance evaluation studies for manufacturers seeking compliance under EU MDR 2017/745, IVDR 2017/746, US FDA, and Indian CDSCO regulatory frameworks.
 
With over two decades of combined leadership experience in regulatory affairs, clinical strategy, and medical device research, Reghelps SRC brings together expert clinicians, biostatisticians, and regulatory specialists to deliver high quality, evidence-based outcomes for global regulatory submissions.
 
Bridging Clinical Research and Regulatory Compliance
Reghelps SRC provides end-to-end clinical study management in India, including protocol design, site selection, ethics committee approvals, patient recruitment, data management, and final clinical report preparation.
 
The team of experienced clinical research professionals, investigators, and data analysts ensures that all studies strictly adhere to global standards.
 
"Our mission is to help global medical device and IVD manufacturers conduct reliable, regulatory-compliant studies in India with faster turnaround times and superior data integrity," said Mr. Soio George, Founder and CEO at Reghelps SRC. "By combining deep regulatory knowledge with hands-on research experience, we bring efficiency and trust to every stage of clinical investigation and performance evaluation."
 
Clinical Research Services for Medical Devices
<ul style="margin-bottom:11px">
<li style="margin-left:8px">Clinical Investigation Studies: Pilot, pivotal, and post-market studies compliant with EU MDR 2017/745 and ISO 14155.</li>
<li style="margin-left:8px">Post-Market Clinical Follow-up (PMCF): Real-world clinical data collection to maintain CE certification and optimize device performance.</li>
<li style="margin-bottom:11px; margin-left:8px">Usability Engineering: Human factors validation and usability assessments to ensure safe and effective device use.</li>
</ul>
 
Performance Evaluation and Research for IVD Devices
<ul style="margin-bottom:11px">
<li style="margin-left:8px">Analytical Performance Evaluation: Validation of precision, accuracy, sensitivity, specificity, and detection limits of IVD assays.</li>
<li style="margin-left:8px">Clinical Performance Evaluation: Execution of studies to demonstrate clinical validity in real-world healthcare settings.</li>
<li style="margin-bottom:11px; margin-left:8px">Post-Market Performance Follow-up (PMPF): Continuous monitoring to ensure IVDR 2017/746 compliance.</li>
</ul>
 
Regulatory and Statistical Support
Regulatory and Statistical Support services include Clinical Evaluation Plans (CEP), Clinical Investigation Plans (CIP), Statistical Analysis Plans (SAP), and Comprehensive Study Reports and Summary Documentation. Each document is prepared to meet international regulatory standards, ensuring robust clinical evidence for CE Marking, IVDR, FDA, and other global submissions.
 
These services are designed to assist medical device startups, established manufacturers, and global regulatory consultants in India and abroad. By partnering with Reghelps SRC, manufacturers gain a reliable CRO partner for clinical investigations, PMCF studies, and IVD performance evaluation services, enabling faster, compliant, and high-quality regulatory submissions.
 
Driving Clinical Research Excellence in India
With advanced data collection tools, dedicated clinical project managers, and an established network of hospitals and laboratories, Reghelps SRC ensures efficient project execution with full regulatory transparency. In collaboration with <a href="https://www.i3cglobal.com/" style="color:#467886; text-decoration:underline">I3CGLOBAL</a>, the company provides a seamless connection between clinical research execution and regulatory documentation, supporting submissions for CE Marking, UKCA, TGA, CDSCO, and FDA approvals.
 
"Together with I3CGLOBAL, we aim to make India a strong hub for medical device and IVD research," added by Mr. NagaChandra Bhardwaj, Co-founder and CTO. "Our goal is to provide reliable, ethical, and scientifically valid study outcomes that help manufacturers achieve regulatory compliance."
<img id='img_pixel' src='https://bwi-api-react.businesswireindia.com/images/pixel.gif' alt='' width='0' height='0' border='0' loaded='' onload="javascript:if(document.getElementById('img_pixel').getAttribute('loaded')==''){document.getElementById('img_pixel').src='https://bwi-api-react.businesswireindia.com/api/BWIWesiteGet/partnerSiteAnalytics?value=ro2nF2C29LqAocxkKhXQjwhuoReDILUvqAhNf8LkFSl81Ag%3D&referrer='+encodeURIComponent(document.referrer)+'&current='+encodeURIComponent(document.URL);document.getElementById('img_pixel').setAttribute('loaded','k');}" /> Disclaimer: The above press release comes to you under an arrangement with Business Wire India. We take no editorial responsibility for the same.
]]></content:encoded>
<wfw:commentRss>https://nynewscast.com/reghelps-src-launches-specialized-clinical-investigation-pmcf-and-ivd-performance-evaluation-services-in-india-183773/feed/</wfw:commentRss>
<slash:comments>0</slash:comments>
</item>
<item>
<title>KLC DEADLINE ALERT: Hagens Berman Alerts KinderCare (KLC) Investors to Today’s Lead Plaintiff Deadline in Securities Class Action</title>
<link>https://nynewscast.com/klc-deadline-alert-hagens-berman-alerts-kindercare-klc-investors-to-todays-lead-plaintiff-deadline-in-securities-class-action-183767/</link>
<comments>https://nynewscast.com/klc-deadline-alert-hagens-berman-alerts-kindercare-klc-investors-to-todays-lead-plaintiff-deadline-in-securities-class-action-183767/#respond</comments>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 09:57:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/klc-deadline-alert-hagens-berman-alerts-kindercare-klc-investors-to-todays-lead-plaintiff-deadline-in-securities-class-action-183767/</guid>
<description><![CDATA[SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ — A new securities class action lawsuit has been filed against KinderCare Learning Companies, Inc. (NYSE: KLC) and its executives, alleging the company misled investors during its October 2024 Initial Public Offering (IPO). The lawsuit, styled Gollapalli v. KinderCare Learning Companies, Inc., et al., seeks to represent investors who […]]]></description>
<content:encoded><![CDATA[
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ — A new securities class action lawsuit has been filed against KinderCare Learning Companies, Inc. (NYSE: KLC) and its executives, alleging the company misled investors during its October 2024 Initial Public Offering (IPO). The lawsuit, styled Gollapalli v. KinderCare Learning Companies, Inc., et al., seeks to represent investors who purchased KLC common stock in or traceable to the company’s IPO.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">

<a href="https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg" title="Class Action (PRNewsfoto/Hagens Berman Sobol Shapiro LLP)" alt="Class Action (PRNewsfoto/Hagens Berman Sobol Shapiro LLP)"></img> 
</a>

</div>
The lawsuit claims that KinderCare’s IPO documents painted a false and misleading picture of the company’s operations. While the company described its services as providing “the highest quality care possible” in a “safe, nurturing and engaging environment,” the complaint alleges these statements were contradicted by a documented history of serious safety and care failures that were concealed from investors.
Hagens Berman urges KinderCare investors who suffered substantial losses to <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4531879-1&h=1176025557&u=https%3A%2F%2Fwww.hbsslaw.com%2Finvestor-fraud%2Fklc&a=contact+the+firm+now" target="_blank" rel="nofollow">contact the firm now</a>.

Class Period: Purchasers in KinderCare October 2024 IPO Lead Plaintiff Deadline: Oct. 14, 2025 Visit:<a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4531879-1&h=70502145&u=https%3A%2F%2Fwww.hbsslaw.com%2Finvestor-fraud%2Fklc&a=www.hbsslaw.com%2Finvestor-fraud%2Fklc" target="_blank" rel="nofollow">www.hbsslaw.com/investor-fraud/klc</a> Contact the Firm Now: <a href="mailto:KLC@hbsslaw.com" target="_blank" rel="nofollow">KLC@hbsslaw.com</a> 844-916-0895

Federal Subsidies and Unforeseen Risks

The lawsuit highlights that more than 30% of KinderCare’s revenues come from federal subsidies, making the alleged omissions particularly significant. According to the complaint, the company’s failure to disclose a history of child neglect and harm exposed it to a material, undisclosed risk of legal and regulatory action that could threaten this major revenue source.
Since the IPO, KinderCare’s stock has performed poorly, dropping from its offering price of $24 per share to lows near $9 per share. The lawsuit attributes this decline to the market’s realization that the company’s positive statements were unfounded.

Hagens Berman’s Investor Investigation

National plaintiffs’ rights firm Hagens Berman is investigating these claims and encourages investors who purchased KLC stock in the IPO and suffered losses to consider their legal options. The firm is focused on the extent to which the company’s alleged history of safety and care failures was concealed from the public, leading to an artificially inflated IPO price and subsequent investor losses.
“Our investigation is focused on the fundamental disconnect between how KinderCare presented itself to investors in its IPO and the alleged reality of its operations. The lawsuit claims investors were sold on a promise of ‘high-quality care’ while being kept in the dark about a history of safety and neglect issues. We are focusing on whether this alleged failure to disclose key risks to the business and revenue streams constitutes a violation of the U.S. securities laws,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in KinderCare and have substantial losses, or have knowledge that may assist the firm’s investigation, <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4531879-1&h=1032675702&u=https%3A%2F%2Fwww.hbsslaw.com%2Finvestor-fraud%2Fklc&a=submit+your+losses+now" target="_blank" rel="nofollow">submit your losses now</a> »
If you’d like more information and answers to frequently asked questions about the KinderCare case and our investigation, <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4531879-1&h=3283550109&u=https%3A%2F%2Fwww.hbsslaw.com%2Fcases%2Fkindercare-learning-companies-inc-klc-securities-class-action&a=read+more%C2%A0%C2%BB" target="_blank" rel="nofollow">read more »</a>

Whistleblowers: Persons with non-public information regarding KinderCare should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email <a href="mailto:KLC@hbsslaw.com" target="_blank" rel="nofollow">KLC@hbsslaw.com</a>.

<a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4531879-1&h=2439171279&u=https%3A%2F%2Fwww.hbsslaw.com%2F&a=About+Hagens+Berman" target="_blank" rel="nofollow">About Hagens Berman</a>

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4531879-1&h=1960452598&u=https%3A%2F%2Fwww.hbsslaw.com%2F&a=hbsslaw.com" target="_blank" rel="nofollow">hbsslaw.com</a>. Follow the firm for updates and news at <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4531879-1&h=1313337080&u=https%3A%2F%2Fwww.twitter.com%2FClassActionLaw&a=%40ClassActionLaw" target="_blank" rel="nofollow">@ClassActionLaw</a>.

<img loading="lazy" decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=SF96948&sd=2025-10-14"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/klc-deadline-alert-hagens-berman-alerts-kindercare-klc-investors-to-todays-lead-plaintiff-deadline-in-securities-class-action-302582793.html" target="_blank">https://www.prnewswire.com/news-releases/klc-deadline-alert-hagens-berman-alerts-kindercare-klc-investors-to-todays-lead-plaintiff-deadline-in-securities-class-action-302582793.html</a>
SOURCE Hagens Berman Sobol Shapiro LLP
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=SF96948&Transmission_Id=202510140557PR_NEWS_USPR_____SF96948&DateId=20251014" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. NYnewscast.com takes no editorial responsibility for the same.
]]></content:encoded>
<wfw:commentRss>https://nynewscast.com/klc-deadline-alert-hagens-berman-alerts-kindercare-klc-investors-to-todays-lead-plaintiff-deadline-in-securities-class-action-183767/feed/</wfw:commentRss>
<slash:comments>0</slash:comments>
</item>
<item>
<title>‘NBA Cares x Sands Cares Community Impact Week’ a Success</title>
<link>https://nynewscast.com/nba-cares-x-sands-cares-community-impact-week-a-success-183768/</link>
<comments>https://nynewscast.com/nba-cares-x-sands-cares-community-impact-week-a-success-183768/#respond</comments>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 09:51:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/nba-cares-x-sands-cares-community-impact-week-a-success-183768/</guid>
<description><![CDATA[Five days of community engagement unites over 2,200 volunteers and community members NBA stars join forces to spread compassion through basketball MACAO, Oct. 14, 2025 /PRNewswire/ — The final showdown of The NBA China Games 2025 took the court Sunday at The Venetian Arena. Alongside the games, the “NBA Cares x Sands Cares Community Impact […]]]></description>
<content:encoded><![CDATA[
Five days of community engagement unites over 
2,200 
 volunteers and community members


NBA stars join forces to spread compassion through basketball


MACAO, Oct. 14, 2025 /PRNewswire/ — The final showdown of The NBA China Games 2025 took the court Sunday at The Venetian Arena. Alongside the games, the “NBA Cares x Sands Cares Community Impact Week” wrapped up a fun and meaningful week of community outreach events. Running Oct. 8-12, the five-day initiative built on the excitement of the major international sports event to bring together diverse local communities in Macao. More than 2,200 volunteers and community members participated, including the Sands Cares Ambassadors.
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">

<a href="https://mma.prnewswire.com/media/2795616/1.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/2795616/1.jpg" title="Students get ready to go for the jump ball during Wednesday’s youth basketball exchange at Lou Hau High School, the first event of the “NBA Cares x Sands Cares Community Impact Week.”" alt="Students get ready to go for the jump ball during Wednesday’s youth basketball exchange at Lou Hau High School, the first event of the “NBA Cares x Sands Cares Community Impact Week.”"></img> 
</a>

</div>
Jointly organised by NBA Cares and Sands Cares, the community impact week fostered compassion and interaction through a series of inclusive and engaging activities. These included a basketball exchange at a local school, distributing boxed lunches in the community, a community basketball carnival, and the “Her Time to Play” clinic. NBA Legends such as Mitch Richmond, Tim Hardaway, Yao Ming, Shawn Marion, and Deron Williams, alongside current players from the Phoenix Suns and Brooklyn Nets, used basketball as a bridge to extend NBA Cares’ community spirit to Macao, creating a positive impact across the city.
Patrick Dumont, president and chief operating officer of Las Vegas Sands Corp., said: “As far back as the opening of Sands Macao in 2004, our company has placed service to the Macao community among our top priorities. Over the course of two decades now, our dedicated team member volunteers have given their time and energy to make a meaningful difference in this community.
“NBA Cares and Sands Cares have been outstanding partners for this five-day community impact initiative during The NBA China Games 2025. We are excited to see the positive effect in the community, especially on local youth, children, and those in need. We appreciate all who participated and gave their support.”
Dr. Wilfred Wong, executive vice chairman of Sands China Ltd., said: “We are thrilled to have partnered with NBA Cares to bring the community impact week to life. Not only did we invite NBA Legends and players to engage directly with the Macao community, sharing skills with local students and with rural coaches and students from Guizhou and Inner Mongolia, but we also distributed boxed lunches to the underprivileged and connected closely with members of social service organisations. These activities and more fully demonstrated the powerful impact that sports-driven philanthropy can have on our community.
“We extend heartfelt thanks to NBA Cares for their strong support, the passionate participation of NBA Legends and players, the enthusiastic cooperation of local service organisations and schools, and the wholehearted involvement of students and teachers from Macao and those who travelled from the Chinese Mainland. We also express deep gratitude to our Sands Cares Ambassadors and other volunteers for their selfless contributions. The collective efforts of all who were involved made this week more impactful and meaningful. Looking ahead, Sands China will continue to make use of its resources to give back to the Macao community, taking concrete actions to care for society and help more people feel the warmth of community support.”

Events of the “NBA Cares x Sands Cares Community Impact Week”

The community impact week kicked off Oct. 8 with a youth basketball exchange, where NBA Legend Mitch Richmond and NBA coaches provided basketball training and mentorship to 200 students from Lou Hau High School, together with 12 coaches and students from NBA Cares’ “Her Time to Play” initiative who travelled to Macao from rural Guizhou and Inner Mongolia. Richmond and Dr. Wong donated basketballs and training equipment to the school on behalf of NBA and Sands China, supporting the continued development of its basketball programme. The event concluded with an exciting five-on-five skills challenge.
An official tip-off event on Oct. 9 at The Venetian Arena was attended by Adam Silver, NBA commissioner; Yao Ming, Naismith Memorial Hall of Famer and chairman of the Yao Foundation; Patrick Dumont, president and chief operating officer of Las Vegas Sands Corp.; Dr. Wong; Grant Chum, chief executive officer and executive director of Sands China Ltd.; and Dave Sun, executive vice president and chief financial officer of Sands China Ltd. and managing director of Venetian Macau Limited. Phoenix Suns and Brooklyn Nets players led a basketball clinic for over 60 participants, including students from Lou Hau High School, Sheng Kung Hui Choi Kou School (Macau), and Yuet Wah College Macau, and the “Her Time to Play” coaches and students. Together with Sands Cares Ambassadors, they packed goodie bags and health kits to distribute in the local community.
The third event – a boxed lunch distribution initiative – on Oct. 10 featured NBA Legend Tim Hardaway, Grant Chum, the “Her Time to Play” coaches, volunteers from the Yao Foundation, and Sands Cares Ambassadors. They visited the Fuhong Society of Macau’s Pou Choi Centre, where they distributed boxed lunches and health kits to 200 local residents in need – sending warmth and compassion to the community.
The community basketball carnival took place Oct. 11 in the NBA House at The Venetian® Macao, welcoming 120 family members of local social service organisations to enjoy interactive sports-themed games and exciting performances. NBA Legend Shawn Marion shared some basketball fun with participants and Sands Global Ambassador David Beckham came to support the event. Other attending guests included: Patrick Dumont; Ron Reese, senior vice president of global communications and corporate affairs of Las Vegas Sands Corp.; Zachary Hudson, executive vice president and global general counsel of Las Vegas Sands Corp.; Dr. Wong; and Dave Sun.
The finale event on Oct. 12 was the “Her Time to Play” basketball clinic at the NBA House, featuring NBA Legend Deron Williams and current WNBA player Myisha Hines-Allen. They shared their training tips and experience with girls’ basketball team members from Pui Ching Middle School Macau and Keng Peng School, and with the “Her Time to Play” students and coaches, encouraging them to pursue their dreams. The event culminated in an exciting five-on-five friendly skills challenge, marking a perfect conclusion to the community impact week.
Joining the aforementioned guests, other guests throughout community impact week included: Mark Tatum, deputy commissioner and chief operating officer of the NBA; Kathy Behrens, president of social responsibility and player programs for the NBA; Andre Iguodala, NBA Legend and executive director of the National Basketball Players Association (NBPA); Micheal Ma, CEO of NBA Asia Pacific; and Wayne Chang, managing director of NBA Asia.
More than 300 volunteers, including Sands Cares Ambassadors, served the attendees of community impact week. In recognition of their selfless dedication, Sands China will present each volunteer with a certificate of appreciation.
Sands China established the Sands Cares Ambassador Programme in 2009, providing an organised platform for team members to continue serving the community. During the programme’s 15th anniversary last year, Sands China called on all sectors of society to answer the call to “#BeMyVolunteer” and join the company’s effort to encourage more people to volunteer with Macao’s social service organisations.
Sands China carries out its community initiatives, like the impact week and the Sands Cares Ambassador Programme, under the <a href="https://www.sands.com/sands-cares/" target="_blank" rel="nofollow">Sands Cares</a> global corporate citizenship programme. With Sands China being an important stakeholder in the local community, the Sands Cares is an influential tool to carry out the company’s unwavering commitment to contribute to society, serving as an important connection between Sands China and local residents.

About Sands China Ltd. 

Sands China Ltd. (Sands China or the Company) is incorporated in the Cayman Islands with limited liability and is listed on The Stock Exchange of Hong Kong Limited (HKEx: 1928). Sands China is the largest operator of integrated resorts in Macao. The Company’s integrated resorts on the Cotai Strip comprise The Venetian® Macao, The Plaza® Macao, The Parisian® Macao and The Londoner Macao®. The Company also owns and operates Sands® Macao on the Macao peninsula. The Company’s portfolio features a diversified mix of leisure and business attractions and transportation operations, including large meeting and convention facilities; a wide range of restaurants; shopping malls; world-class entertainment at The Venetian Arena, The Londoner Arena, The Venetian Theatre, The Parisian Theatre, the Londoner Theatre and the Sands Theatre; and a high-speed Cotai Water Jet ferry service between Hong Kong and Macao. The Company’s Cotai Strip portfolio has the goal of contributing to Macao’s transformation into a world centre of tourism and leisure. Sands China is a subsidiary of global resort developer <a href="http://www.sands.com/" target="_blank" rel="nofollow">Las Vegas Sands Corp.</a> (NYSE: LVS).
For more information, please visit <a href="http://www.sandschina.com/" target="_blank" rel="nofollow">www.sandschina.com</a>.

About Sands Cares

A firm believer in the importance of corporate social responsibility, Sands China Ltd. engages with the local Macao community as a part of Sands Cares – the charitable giving programme of parent company Las Vegas Sands Corp. Sands Cares integrates the company’s philanthropic work worldwide in four key areas: financial giving, community problem solving and collaboration, in-kind donations, and team member volunteerism.
Key areas of Sands Cares in Macao include the Sands Cares Ambassador programme for volunteering in the local community; charitable contributions to NGOs and community organisations; and sponsorship of community events.
For more information, please visit <a href="https://www.sands.com/sands-cares/" target="_blank" rel="nofollow">www.sands.com/sands-cares/</a> 

About NBA Social Impact & Inclusion and NBA Cares

NBA Social Impact & Inclusion drives change on issues facing fans and communities by advancing needed resources and proven partners while creating data-driven strategies and programming to impact the NBA ecosystem and empower colleagues to bring their best self to work to drive global success. NBA Cares works with NBA players and teams to highlight important issues through the NBA’s digital, social and broadcast channels, live events and partnerships.

Media contacts: Corporate Communications, Sands China Ltd. Mabel Wu Tel: +853 8118 2268 Email: <a href="mailto:mabel.wu@sands.com.mo" target="_blank" rel="nofollow">mabel.wu@sands.com.mo</a> 
Jesse Chiang Tel: +853 8118 2054 Email: <a href="mailto:jesse.chiang@sands.com.mo" target="_blank" rel="nofollow">jesse.chiang@sands.com.mo</a>
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder2">

<a href="https://mma.prnewswire.com/media/2795617/2.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/2795617/2.jpg" title="The “NBA Cares x Sands Cares Community Impact Week” holds its official tip-off event Thursday at The Venetian Arena." alt="The “NBA Cares x Sands Cares Community Impact Week” holds its official tip-off event Thursday at The Venetian Arena."></img> 
</a>


<a href="https://mma.prnewswire.com/media/2795621/3.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/2795621/3.jpg" title="Volunteers help box lunches to distribute to the community in the third event of the “NBA Cares x Sands Cares Community Impact Week,” held Friday at the Fuhong Society of Macau’s Pou Choi Centre." alt="Volunteers help box lunches to distribute to the community in the third event of the “NBA Cares x Sands Cares Community Impact Week,” held Friday at the Fuhong Society of Macau’s Pou Choi Centre."></img>
</a>


<a href="https://mma.prnewswire.com/media/2795626/4.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/2795626/4.jpg" title="The community basketball carnival delivers interactive sports-themed games and exciting performances Saturday in the NBA House at The Venetian Macao." alt="The community basketball carnival delivers interactive sports-themed games and exciting performances Saturday in the NBA House at The Venetian Macao."></img> 
</a>


<a href="https://mma.prnewswire.com/media/2795625/5.html" target="_blank" rel="nofollow"> 
<img decoding="async" src="https://mma.prnewswire.com/media/2795625/5.jpg" title="Youth enjoy the finale event of Community Impact Week, the “Her Time to Play” basketball clinic, Sunday at the NBA House at The Venetian Macao." alt="Youth enjoy the finale event of Community Impact Week, the “Her Time to Play” basketball clinic, Sunday at the NBA House at The Venetian Macao."></img> 
</a>

</div>

<img loading="lazy" decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=HK97245&sd=2025-10-14"></img> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/nba-cares-x-sands-cares-community-impact-week-a-success-302583253.html" target="_blank">https://www.prnewswire.com/news-releases/nba-cares-x-sands-cares-community-impact-week-a-success-302583253.html</a>
SOURCE Sands China Ltd.
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=HK97245&Transmission_Id=202510140551PR_NEWS_USPR_____HK97245&DateId=20251014" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. NYnewscast.com takes no editorial responsibility for the same.
]]></content:encoded>
<wfw:commentRss>https://nynewscast.com/nba-cares-x-sands-cares-community-impact-week-a-success-183768/feed/</wfw:commentRss>
<slash:comments>0</slash:comments>
</item>
<item>
<title>Invitation to presentation of Electrolux Group Q3 report</title>
<link>https://nynewscast.com/invitation-to-presentation-of-electrolux-group-q3-report-183769/</link>
<comments>https://nynewscast.com/invitation-to-presentation-of-electrolux-group-q3-report-183769/#respond</comments>
<dc:creator><![CDATA[PR Newswire]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 09:41:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/invitation-to-presentation-of-electrolux-group-q3-report-183769/</guid>
<description><![CDATA[STOCKHOLM, Oct. 14, 2025/PRNewswire/ — On 30th of October, Electrolux Group will publish the results for the third quarter of 2025, at approx. 07.00 CET. Media, investors and analysts are invited to a simultaneous video webcast and telephone conference on the same day following the release of the results, starting at 09.00 CET where Yannick Fierling, […]]]></description>
<content:encoded><![CDATA[
STOCKHOLM, Oct. 14, 2025/PRNewswire/ — On 30th of October, Electrolux Group will publish the results for the third quarter of 2025, at approx. 07.00 CET. 
Media, investors and analysts are invited to a simultaneous video webcast and telephone conference on the same day following the release of the results, starting at 09.00 CET where Yannick Fierling, President and CEO, together with Therese Friberg, CFO, will present the report.
Information on how to join the video webcast and telephone conference is available <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4532183-1&h=2264230064&u=https%3A%2F%2Fwww.electroluxgroup.com%2Fen%2Fevent%2Finterim-report-january-september-2025%2F&a=HERE" target="_blank" rel="nofollow">HERE</a>.
Slides used in the presentation and report will be available at the Group’s website, <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4532183-1&h=2157135546&u=http%3A%2F%2Fwww.electroluxgroup.com%2Fir&a=www.electroluxgroup.com%2Fir" target="_blank" rel="nofollow">www.electroluxgroup.com/ir</a>.

For more information: Ann-Sofi Jönsson, Head of Investor Relations & Sustainability Reporting, +46 73 035 1005 Maria Åkerhielm, Investor Relations Manager, +46 70 796 3856 Henry Sjölin, Investor Relations Manager, +46 76 863 51 85 Electrolux Group Press Hotline, +46 8 657 65 07
This information was brought to you by Cision <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4532183-1&h=1760189206&u=http%3A%2F%2Fnews.cision.com%2F&a=http%3A%2F%2Fnews.cision.com" target="_blank" rel="nofollow">http://news.cision.com</a>

<a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4532183-1&h=534787068&u=https%3A%2F%2Fnews.cision.com%2Felectrolux-group%2Fr%2Finvitation-to-presentation-of-electrolux-group-q3-report%2Cc4249775&a=https%3A%2F%2Fnews.cision.com%2Felectrolux-group%2Fr%2Finvitation-to-presentation-of-electrolux-group-q3-report%2Cc4249775" target="_blank" rel="nofollow">https://news.cision.com/electrolux-group/r/invitation-to-presentation-of-electrolux-group-q3-report,c4249775</a>

The following files are available for download:
<div>
<table border="0" cellspacing="0" cellpadding="1">
<tr>
<td class="prngen1" colspan="1" rowspan="1">

 
<a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4532183-1&h=3777303216&u=https%3A%2F%2Fmb.cision.com%2FMain%2F1853%2F4249775%2F3720803.pdf&a=https%3A%2F%2Fmb.cision.com%2FMain%2F1853%2F4249775%2F3720803.pdf" target="_blank" class="prnews_a" rel="nofollow">https://mb.cision.com/Main/1853/4249775/3720803.pdf</a> 


</td>
<td class="prngen1" colspan="1" rowspan="1">

Invitation Q3 2025

</td>
</tr>
</table></div>
 

<img loading="lazy" decoding="async" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=IO97270&sd=2025-10-14"></img> View original content:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/invitation-to-presentation-of-electrolux-group-q3-report-302583246.html" target="_blank">https://www.prnewswire.com/news-releases/invitation-to-presentation-of-electrolux-group-q3-report-302583246.html</a>
SOURCE Electrolux Group
 <img decoding="async" alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=IO97270&Transmission_Id=202510140541PR_NEWS_USPR_____IO97270&DateId=20251014" style="border:0px; width:1px; height:1px;"></img>Disclaimer: The above press release comes to you under an arrangement with PR Newswire. NYnewscast.com takes no editorial responsibility for the same.
]]></content:encoded>
<wfw:commentRss>https://nynewscast.com/invitation-to-presentation-of-electrolux-group-q3-report-183769/feed/</wfw:commentRss>
<slash:comments>0</slash:comments>
</item>
<item>
<title>Himax to Showcase WiseEye Palm Vein Authentication Featuring On-Device AI and GDPR-Compliant Privacy at Sectech Sweden 2025</title>
<link>https://nynewscast.com/himax-to-showcase-wiseeye-palm-vein-authentication-featuring-on-device-ai-and-gdpr-compliant-privacy-at-sectech-sweden-2025-183757/</link>
<dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 09:32:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/himax-to-showcase-wiseeye-palm-vein-authentication-featuring-on-device-ai-and-gdpr-compliant-privacy-at-sectech-sweden-2025-183757/</guid>
<description><![CDATA[Featuring Privacy-first, Ultralow Power AI Biometric Innovations to Enable Secure, Contactless, High-Speed Authentication for Next-Generation Access Control Applications TAINAN, Taiwan, Oct. 14, 2025 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or the “Company”) (Nasdaq: HIMX), a leading provider of fabless display driver ICs and other semiconductor solutions, has announced it will showcase its WiseEye™ ultralow […]]]></description>
<content:encoded><![CDATA[Featuring Privacy-first, Ultralow Power AI Biometric Innovations to Enable Secure, Contactless, High-Speed Authentication for Next-Generation Access Control Applications
TAINAN, Taiwan, Oct. 14, 2025 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or the “Company”) (Nasdaq: HIMX), a leading provider of fabless display driver ICs and other semiconductor solutions, has announced it will showcase its WiseEye<img src="https://s.w.org/images/core/emoji/16.0.1/72x72/2122.png" alt="™" class="wp-smiley" style="height: 1em; max-height: 1em;" /> ultralow power AI technology spotlighting its palm vein authentication capabilities at Sectech Sweden 2025, an exhibition event focused on security solutions, taking place from Oct. 14 -15, 2025 in Sweden.
WiseEye<img src="https://s.w.org/images/core/emoji/16.0.1/72x72/2122.png" alt="™" class="wp-smiley" style="height: 1em; max-height: 1em;" /> palm vein authentication delivers a contactless and hygienic user experience, enabling rapid identity verification in under 100 milliseconds. It features industry-leading performance with a False Acceptance Rate (FAR) below 1% and superior liveness detection accuracy, making it ideal for seamless integration into diverse access control environments. Built on a privacy-first architecture, WiseEye employs on-device AI to perform real-time palm vein recognition entirely on endpoint devices, eliminating biometric data storage and ensuring maximum privacy and user trust. Moreover, Himax’s biometric authentication portfolio complies with Europe’s General Data Protection Regulation (GDPR), one of the world’s most stringent data privacy laws, ensuring strong privacy protection and enabling adoption in highly regulated markets. Proven in mass production across a wide range of access control devices, the WiseEye PalmVein Module offers a compact, lightweight, and secure embedded biometric solution with strong privacy protection. The module is certified to PSA (Platform Security Architecture) Level 2, attesting to its compliance with rigorous industry security standards.
During the event, Himax will also unveil its expanded biometric suite, a bimodal authentication solution combining palm vein and facial recognition, meticulously designed to meet customer demand for greater flexibility in smart door locks under all environmental conditions. By integrating two biometric modalities, it enhances both security and user convenience, representing a significant breakthrough in biometric technology for battery-powered smart devices.
Himax invites all interested parties to stop by our exhibition booth at C6:47 (Stockholmsmässan, Älvsjö, Sweden) to experience the future of biometric authentication firsthand. To schedule a meeting or booth tour, please contact Himax at <a href="https://www.globenewswire.com/Tracker?data=laY-JQH51X6_8xeJ6onq1AsQFFuq-AOt7Kn0YWwFceRnI09gpOx3CnmIn1tZllqmNAegdC9CRQhJmL-gDNGbR7X5PRSVVv0M92FOvFfHjZ4=" rel="nofollow" target="_blank" title="HX_WISEEYE@himax.com.tw">HX_WISEEYE@himax.com.tw</a>.
About Himax Technologies, Inc.
Himax Technologies, Inc. (NASDAQ: HIMX) is a leading global fabless semiconductor solution provider dedicated to display imaging processing technologies. The Company’s display driver ICs and timing controllers have been adopted at scale across multiple industries worldwide including TVs, PC monitors, laptops, mobile phones, tablets, automotive, ePaper devices, industrial displays, among others. As the global market share leader in automotive display technology, the Company offers innovative and comprehensive automotive IC solutions, including traditional driver ICs, advanced in-cell Touch and Display Driver Integration (TDDI), local dimming timing controllers (Local Dimming Tcon), Large Touch and Display Driver Integration (LTDI) and OLED display technologies. Himax is also a pioneer in tinyML visual-AI and optical technology related fields. The Company’s industry-leading WiseEyeTM Ultralow Power AI Sensing technology which incorporates Himax proprietary ultralow power AI processor, always-on CMOS image sensor, and CNN-based AI algorithm has been widely deployed in consumer electronics and AIoT related applications. Himax optics technologies, such as diffractive wafer level optics, LCoS microdisplays and 3D sensing solutions, are critical for facilitating emerging AR/VR/metaverse technologies. Additionally, Himax designs and provides touch controllers, OLED ICs, LED ICs, EPD ICs, power management ICs, and CMOS image sensors for diverse display application coverage. Founded in 2001 and headquartered in Tainan, Taiwan, Himax currently employs around 2,200 people from three Taiwan-based offices in Tainan, Hsinchu and Taipei and country offices in China, Korea, Japan, Germany, and the US. Himax has 2,586 patents granted and 371 patents pending approval worldwide as of September 30, 2025.
<a href="https://www.globenewswire.com/Tracker?data=9BQNt0oBIW55kog2lqC5jAAz7ezkAajrKnEPYzaeASHK4auFhx7c2GZvYFt8akAYwrThobCAyW6BbSqKUdMHBCXyc5OZU5Sce-lWTvRi_5A=" rel="nofollow" target="_blank" title="">http://www.himax.com.tw</a>
Forward Looking Statements 
Factors that could cause actual events or results to differ materially from those described in this conference call include, but are not limited to, the effect of the Covid-19 pandemic on the Company’s business; general business and economic conditions and the state of the semiconductor industry; market acceptance and competitiveness of the driver and non-driver products developed by the Company; demand for end-use applications products; reliance on a small group of principal customers; the uncertainty of continued success in technological innovations; our ability to develop and protect our intellectual property; pricing pressures including declines in average selling prices; changes in customer order patterns; changes in estimated full-year effective tax rate; shortage in supply of key components; changes in environmental laws and regulations; changes in export license regulated by Export Administration Regulations (EAR); exchange rate fluctuations; regulatory approvals for further investments in our subsidiaries; our ability to collect accounts receivable and manage inventory and other risks described from time to time in the Company’s SEC filings, including those risks identified in the section entitled “Risk Factors” in its Form 20-F for the year ended December 31, 2024 filed with the SEC, as may be amended.
Company Contacts:
Karen Tiao, Head of IR/PR Himax Technologies, Inc. Tel: +886-2-2370-3999 Fax: +886-2-2314-0877 Email: <a href="https://www.globenewswire.com/Tracker?data=02TLI8ol81-uIp6JlK6tAS5bMSSyskcTYdCvf-BJWWWY5LMToybN08E3H8MnyWCUhLFgh1LAgmyYyl3C4ciOgBYrYgtXsfVTwrs5dFMDDbw=" rel="nofollow" target="_blank" title="hx_ir@himax.com.tw">hx_ir@himax.com.tw</a> <a href="https://www.globenewswire.com/Tracker?data=8kAm5bbMBOiJi1lfQjAoyX3G3NQ9hZXmJJyJ7RODn3f6Rzg87_OufzLcA9CzXJeJgp9qU0q92lhw2AlfKGQB-L4tdYoWv5q6KYYS-NHG0MU=" rel="nofollow" target="_blank" title="www.himax.com.tw">www.himax.com.tw</a>
Mark Schwalenberg, Director Investor Relations – US Representative MZ North America Tel: +1-312-261-6430 Email: <a href="https://www.globenewswire.com/Tracker?data=jghcC2GvHVO2gb2HTZ5k2NZIsaNh7WLaTh5hTsgx1rgP_ufBqRCpuME2wSvegMDJhJbtVhFwSTYznwo3THAQRWxegmIJyFVlZJp2vJwx3Ow=" rel="nofollow" target="_blank" title="HIMX@mzgroup.us">HIMX@mzgroup.us</a> <a href="https://www.globenewswire.com/Tracker?data=GsOmpecvr_iOuzRnVB4QfeX_L5xBgIDCQLcdAV6Hckyqs9s-waWJ77eTcs2mVo8tihgTWoF0gjg0Xos4LUPgFA==" rel="nofollow" target="_blank" title="www.mzgroup.us">www.mzgroup.us</a>
<img alt="" src='https://ml.globenewswire.com/media/YzNmMDk2MzctMDk4ZC00ZWU2LTkyYjgtMTg2MTRkZmU4NTc5LTEwNDAxOTItMjAyNS0xMC0xNC1lbg==/tiny/Himax-Technologies-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. NYnewscast.com takes no editorial responsibility for the same.
]]></content:encoded>
</item>
<item>
<title>From Diversity to Impact: The Power of Diversity Funding Facility Identifies Priority Opportunity Crops for Investment</title>
<link>https://nynewscast.com/from-diversity-to-impact-the-power-of-diversity-funding-facility-identifies-priority-opportunity-crops-for-investment-183758/</link>
<dc:creator><![CDATA[GlobeNewswire]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 09:14:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">https://nynewscast.com/from-diversity-to-impact-the-power-of-diversity-funding-facility-identifies-priority-opportunity-crops-for-investment-183758/</guid>
<description><![CDATA[As the world marks World Food Day on 16 October, the Crop Trust’s Power of Diversity Funding Facility highlights the results of national consultations with stakeholders to identify opportunity crops that boost nutrition, resilience and local livelihoods – key ingredients for a more resilient food future. Sorghum in the field (credit: Crop Trust) Sorghum, often […]]]></description>
<content:encoded><![CDATA[As the world marks World Food Day on 16 October, the Crop Trust’s Power of Diversity Funding Facility highlights the results of national consultations with stakeholders to identify opportunity crops that boost nutrition, resilience and local livelihoods – key ingredients for a more resilient food future.
<div style="float:right;padding:0 0 15px 20px;margin:15px 0 20px 20px;width:300px">
Sorghum in the field (credit: Crop Trust)
<figure>
<img decoding="async" src="https://ml.globenewswire.com/Resource/Download/cdee1fd6-3421-4a88-936b-6b8f035e0681" title="Sorghum in the field (credit: Crop Trust)" alt="Sorghum, often called “the camel of crops,” thrives where few others can — enduring heat, drought, and poor soils. Highly nutritious and rich in fiber, it’s a vital source of food and income for millions in dry regions, playing a key role in global food security." /><figcaption>Sorghum, often called “the camel of crops,” thrives where few others can — enduring heat, drought, and poor soils. Highly nutritious and rich in fiber, it’s a vital source of food and income for millions in dry regions, playing a key role in global food security.</figcaption></figure>
</div>
Bonn, Germany, Oct. 14, 2025 (GLOBE NEWSWIRE) — Horse gram from India and Nigeria’s ancient grain fonio are among the dazzling variety of opportunity crops singled out for special attention in the coming years by over 250 farmers, scientists and policymakers across seven countries. This marks the successful completion of the crucial first step in the work of the <a href="https://www.globenewswire.com/Tracker?data=faDFNk4sjL6EOWT1L5VmnVe42IszYkS81ZYxZ7FGGItT1MzZcoy8XqPbiJqXqg9LvIcookEoBd7axmX8io36zl3sNGbNSUwIAqfAqckc8gRiDFMR0dqjRvO-MQc6gvhdoU-SuDazkF7V74ySo74fDtwi89aKDhqkgy3pC7yLtyL4rdCq4ycs9t45Huml1BVy" rel="nofollow" target="_blank" title="Power of Diversity Funding Facility">Power of Diversity Funding Facility</a>, an ambitious global initiative launched by the Crop Trust earlier this year.
Backed by €10 million from Germany through KfW Development Bank and €2 million from Ireland via its Department of Foreign Affairs, the Funding Facility will promote the conservation, production and consumption of high-potential opportunity crops. These plants are resilient, nutrient-rich and deeply tied to local traditions – yet overlooked by research and investment. Until now.
Across the participating countries, national partners convened inclusive dialogues that brought together farmers, researchers and policymakers to decide which crops should take center stage. This process was supported by the Alliance of Bioversity International and CIAT, which brought to bear decades of expertise on neglected and underutilized crops, particularly in Africa.

<ul>
<li style="margin-top:12pt; margin-bottom:0.0001pt;">Colombia – Agrosavia, supported by the Alliance of Bioversity International and CIAT, guided discussions that highlighted peach palm and chayote for their strong nutritional value and untapped market potential.</li>
<li style="margin-top:0in; margin-bottom:0in;">Nigeria – The National Centre for Genetic Resources and Biotechnology (NACGRAB) led a process that singled out fonio and pigeon pea, both recognized for their role in strengthening resilience and supporting food security in rural and urban diets alike.</li>
<li style="margin-top:0in; margin-bottom:0in;">Zambia – Experts and farmers convened by the Zambia Agricultural Research Institute (ZARI) chose cowpea and sorghum – crops able to withstand harsh conditions while still providing reliable nutrition.</li>
<li style="margin-top:0in; margin-bottom:0in;">Kenya – The Kenya Agricultural and Livestock Research Organization (KALRO) coordinated a dialogue that elevated amaranth, valued for both its leaves and grains, and finger millet, praised for its versatility and cultural importance.</li>
<li style="margin-top:0in; margin-bottom:0in;">India – The M.S. Swaminathan Research Foundation (MSSRF) brought together diverse voices that emphasized horse gram and yams – traditional staples now in need of renewed research attention.</li>
<li style="margin-top:0in; margin-bottom:0in;">Tanzania – The Tanzania Agricultural Research Institute (TARI), working with the Crop Trust’s BOLDER initiative, facilitated a broad consultation that identified finger millet, Bambara groundnut, moringa, sweetpotato (especially its leaves) and jute mallow as priority crops for both nutrition and resilience.</li>
<li style="margin-top:0in; margin-bottom:12pt;">Uganda – Also in partnership with BOLDER, the National Agricultural Research Organization (NARO) led a process that selected jackfruit, pearl millet, pumpkin, cowpea and amaranth for their contribution to diets today and their potential to expand economic opportunities for smallholders.</li>
</ul>

The next phase of the Power of Diversity Funding Facility will build on this momentum, says Nico Wilms-Posen, who coordinates the Funding Facility. Project activities will focus on securing the diversity of the selected crops in genebanks and ensuring it is available to breeders and farmers. 
At the same time, the project will strengthen value chains by improving seed availability, conducting nutritional studies and engaging with consumers to promote these crops. Knowledge will also be shared with national policymakers to help give opportunity crops the recognition they deserve, within the partner countries and beyond.
“These crops were selected by those who know their farming and food systems best,” said Dr Stefan Schmitz, Executive Director of the Crop Trust. “By focusing on opportunity crops, we can meet the challenges facing tomorrow’s food systems. These crops can open economic opportunities for farmers and deliver benefits to communities now, while safeguarding the future of food.”
###
About the Crop Trust The Crop Trust is an international organization working to conserve crop diversity and thus protect global food and nutrition security. At the core of Crop Trust is an endowment fund dedicated to providing guaranteed long-term financial support to key genebanks worldwide. The Crop Trust supports the Svalbard Global Seed Vault and coordinates large-scale projects worldwide to secure crop diversity and make it available for use, globally forever and for the benefit of everyone. The Crop Trust is recognized as an essential element of the funding strategy of the International Treaty on Plant Genetic Resources for Food and Agriculture. Learn more at <a href="https://www.globenewswire.com/Tracker?data=PI6jF2cxkVsTtDUI3IDUtPe-CVJvY1JGccIbMqh3kGxXYdVCdUU_4LXHc9JSeyBkmMDyNMcYg3n_-WlVXz-TWlnAbWk-2APYLd4A_JII9Cc=" rel="nofollow" target="_blank" title="www.croptrust.org">www.croptrust.org</a>
About the Power of Diversity Funding Facility The Power of Diversity Funding Facility is a multi-donor initiative managed by the Crop Trust, dedicated to conserving, cultivating and promoting the consumption of relatively neglected opportunity crops across Africa, Asia, the Pacific, and Latin America and the Caribbean. Learn more: <a href="https://www.globenewswire.com/Tracker?data=fpVukhqi7IUKJX-a4B5ohVYMa1utjThySk57SmdpziD8hwVhW5gzGT4d7kMn10UI8enkdlnCncyadkbBQ1Qc1hNgtVJDiLzmtuaLrhZU8VWbF-PV50apt6sr554wHelGFhQyRy2TH4ljO44az0hh3HWLZdVlEabc2uUXxvIqrmPg1tuLtUlwZHhAlLNYM2y1i-MhdM8CjBFrgc9ecAE76bUqCGwlzgDQMJO3M2pFpew4ZOFZa9JmBVe9j2x9LPGL" rel="nofollow" target="_blank" title="">https://www.croptrust.org/what-we-do/projects/power-of-diversity-funding-facility/</a>

Attachment

<ul id="gnw_attachments_section-items">
<li>
<a target="_blank" href="https://www.globenewswire.com/Tracker?data=d5OE-rHHZIozt0knG_h9HitReGu-t5X-rbf_6X9BsRY4RZKj0-_GfiahPp6JzqT1YSxy2yGn0ubdFdKnJB1AfYGVHNXS7WCL3LrpVaP5LE3zKGI_F6yzxaw9KrLN8PdZ4M4sxYqSwE_UcxLlQ3TUDOSUO9bps81oiDFucX1lW932koaQjtlgJrwbgPR45kPHao__dvLhiPJUsiOTKYOREw==" title="Sorghum in the field (credit: Crop Trust)" rel="nofollow">Sorghum in the field (credit: Crop Trust)</a>
</li>
</ul>
<pre>CONTACT: Petra Pajdakovic
Crop Trust
petra.pajdakovic@croptrust.org
</pre>
<img alt="" src='https://ml.globenewswire.com/media/MTY0NmU3MmUtNjk4MS00MmFhLThkMDEtMzc4M2VmYjBmZGZhLTUwMDE1MzI5OS0yMDI1LTEwLTE0LWVu/tiny/Crop-Trust.png' referrerpolicy='no-referrer-when-downgrade' />Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. NYnewscast.com takes no editorial responsibility for the same.
]]></content:encoded>
</item>
<item>
<title>Wipro Launches its MyWiproVerse Centre in Bengaluru to Redefine Smart Workspaces</title>
<link>https://nynewscast.com/wipro-launches-its-mywiproverse-centre-in-bengaluru-to-redefine-smart-workspaces-183752/</link>
<comments>https://nynewscast.com/wipro-launches-its-mywiproverse-centre-in-bengaluru-to-redefine-smart-workspaces-183752/#respond</comments>
<dc:creator><![CDATA[Business Wire India]]></dc:creator>
<pubDate>Tue, 14 Oct 2025 09:04:00 +0000</pubDate>
<category><![CDATA[Brand Post]]></category>
<guid isPermaLink="false">http://nynewscast.com/wipro-launches-its-mywiproverse-centre-in-bengaluru-to-redefine-smart-workspaces-183752/</guid>
<description><![CDATA[Wipro Commercial and Institutional Business (CIB), (part of the Wipro Consumer Care & Lighting division), today launched MyWiproVerse Bengaluru, an IoT-powered experience hub that combines advanced technology, human-centric design, and sustainable innovation. Business Wire India Wipro Commercial and Institutional Business (CIB), (part of the Wipro Consumer Care & Lighting division), today launched MyWiproVerse Bengaluru, an […]]]></description>
<content:encoded><![CDATA[Wipro Commercial and Institutional Business (CIB), (part of the Wipro Consumer Care & Lighting division), today launched MyWiproVerse Bengaluru, an IoT-powered experience hub that combines advanced technology, human-centric design, and sustainable innovation. 
Business Wire India
Wipro Commercial and Institutional Business (CIB), (part of the Wipro Consumer Care & Lighting division), today launched MyWiproVerse Bengaluru, an IoT-powered experience hub that combines advanced technology, human-centric design, and sustainable innovation. The centre showcases future-ready workspaces featuring IoT enabled lighting systems that support circadian rhythms and ergonomic seating designed for comfort and productivity – demonstrating how next-generation solutions can enhance well-being, boost productivity, and drive environmental responsibility.
This is the fourth MyWiproVerse launch for Wipro CIB following successful openings in Pune, Hyderabad, and Chennai. Building on the strong market response to its earlier centres, Wipro is expanding to Bengaluru with a new 2,500 sq. ft. flagship innovation experience hub. Located in India’s technology capital and home to IT giants, start-ups, and global corporations, Bengaluru is the ideal location for this state-of-the-art facility.
The lighting solutions cater to three key application areas: Modern Workplace Lighting, Industrial Lighting, and Outdoor Lighting. The center also highlights Wipro’s expertise as a Premium Professional Seating brand, with ergonomic solutions spanning offices, auditoriums, stadiums, collaborative and lounge zones, work-from-home setups, and waiting areas across hospitals, education, airports, and banks. Visitors can also explore smart lighting, advanced automation and ergonomic seating solutions through interactive walkthroughs, guided tours and expert led workshops. The experience centre also features many innovations including Dark Sky compliant lighting that reflect Wipro’s commitment to energy efficiency and environmental responsibility.
“Bengaluru thrives on innovation, and its workplaces are rapidly evolving to meet the needs of a highly connected, knowledge driven workforce,” said Anuj Dhir, Senior Vice President and Business Head, Commercial and Institutional Business, Wipro Consumer Care and Lighting. “With MyWiproVerse Bengaluru, we are enabling businesses to reimagine their work environments through smarter technology, thoughtful design and sustainable practices. This is more than a showcase, it is a collaborative hub where organizations can experience, experiment and adopt solutions that enhance performance, improve employee well-being and advance their sustainability goals.”
The launch of MyWiproVerse Bengaluru reinforces Wipro Commercial and Institutional Business’s vision of shaping the future of workspaces in India. By combining innovation, design expertise and sustainable thinking, the company aims to help organizations create environments that inspire people and deliver measurable business outcomes. The centre is now open for business leaders, architects and designers to explore solutions that can transform the way they work.
<img id='img_pixel' src='https://bwi-api-react.businesswireindia.com/images/pixel.gif' alt='' width='0' height='0' border='0' loaded='' onload="javascript:if(document.getElementById('img_pixel').getAttribute('loaded')==''){document.getElementById('img_pixel').src='https://bwi-api-react.businesswireindia.com/api/BWIWesiteGet/partnerSiteAnalytics?value=ohz7jG%2B7cJ4LNnbXorsE%2FggC4XqsbmvbZwgYjaPZm6iOQwg%3D&referrer='+encodeURIComponent(document.referrer)+'&current='+encodeURIComponent(document.URL);document.getElementById('img_pixel').setAttribute('loaded','k');}" /> Disclaimer: The above press release comes to you under an arrangement with Business Wire India. We take no editorial responsibility for the same.
]]></content:encoded>
<wfw:commentRss>https://nynewscast.com/wipro-launches-its-mywiproverse-centre-in-bengaluru-to-redefine-smart-workspaces-183752/feed/</wfw:commentRss>
<slash:comments>0</slash:comments>
</item>
</channel>
</rss>

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

Download the "valid RSS" banner.
Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)
Add this HTML to your page (change the image src attribute if necessary):

<a href="http://www.feedvalidator.org/check.cgi?url=https%3A//nynewscast.com/feed/"><img src="valid-rss-rogers.png" alt="[Valid RSS]" title="Validate my RSS feed" /></a>

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=https%3A//nynewscast.com/feed/

Home · About · News · Docs · Terms